Marc Levesque is a Rheumatology/Immunology physician affiliated with Merck & Co.. OpenAlex indexes 202 publications with 6,907 citations (h-index 45); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5889 Forbes Avenue, Suite 220
Upmc Lupus Center Of Excellence
Pittsburgh, PA 15217
Telephone
412-586-3350Registry record last updated 7 Nov 2013.
Clinical trials
- Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants
Sponsor: University of Pittsburgh
- Nitric Oxide, LPS and the Pathogenesis of Asthma Phase 1
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
2 NIH research awards on record, funded 2009–2013 per NIH RePORTER. The latest:
- Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients
University of Pittsburgh at Pittsburgh
FY2013$282,301R01AR061298 - Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients
University of Pittsburgh at Pittsburgh
FY2012$297,142R01AR061298 - Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients
University of Pittsburgh at Pittsburgh
FY2011$297,126R01AR061298
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Osteoarthritis Year in Review 2016: biomarkers (biochemical markers)
Osteoarthritis and Cartilage
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Lubiniecki, MD
Merck & Co.
Luther Clark, MD
Merck & Co.
Alfred Saah, MD
Merck & Co.
Keith Kaufman, MD
Merck & Co.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”